PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 23 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Covexir (F. foetida oleo-gum) significantly inhibited cough compared to placebo [PMID: 35896167]
Ethanolic extract of FFBR umbel significantly decreased ulcer area, showing efficacy superior to omeprazole [PMID: 34561804]
Hydroalcoholic extract of stems reduced systolic blood pressure and oxidative stress in dexamethasone-induced hypertensive rats [PMID: 26600859]
Extracts reversed gentamicin-induced nephrotoxicity, reducing blood urea nitrogen and serum creatinine [PMID: 27847458]
Ferulic acid decreased cell viability and suppressed metastatic potential in MDA-MB-231 cells [PMID: 27177074]
Evidence summary
PubMed sources
- 1.PMID: 12444696 (2002) — Polysulfide derivatives from Ferula foetida. · Journal of natural products
- 2.PMID: 33155997 (2021) — Possible role of Unani Pharmacology in COVID-19 - a narrative review. · Reviews on environmental health
- 3.PMID: 37361940 (2023) — Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials. · Infection and drug resistance
- 4.PMID: 34561804 (2022) — Therapeutic potential of Ferula foetida(Bunge) Regel on gastric ulcer model in rats. · Environmental science and pollution research international
- 5.PMID: 35896167 (2022) — Efficacy of Covexir® (Ferula foetida oleo-gum) treatment in symptomatic improvement of patients with mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial.